Novellino, Ettore

Nanopharmaceutics: part I-Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU

Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics

Nanoparticle-Based Drug DeliveryPharmaceutical studies and practices

Cited by 144

Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor

Costa, B., Bendinelli, S., Gabelloni, P., Da Pozzo, E., Daniele, S., Scatena, F., Vanacore, R., Campiglia, P., Bertamino, A., Gomez-Monterrey, I., et al. (2013) · PLoS ONE

Cancer-related Molecular PathwaysGlioma Diagnosis and Treatment

Cited by 79

Probiotic species in the modulation of the anticancer immune response

Marinelli, L., Tenore, G. C., & Novellino, E. (2017) · Seminars in Cancer Biology

Probiotics and Fermented FoodsGut microbiota and health

Cited by 64

Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators

Ostacolo, C., Miceli, F., Di Sarno, V., Nappi, P., Iraci, N., Soldovieri, M. V., Ciaglia, T., Ambrosino, P., Vestuto, V., Lauritano, A., et al. (2020) · Journal of Medicinal Chemistry

Ion channel regulation and functionHeterocyclic Compound Synthesis and Bioactivity

Cited by 39